- •
The T-cell receptor excision circle (TREC) assay is an effective screening tool for severe combined immunodeficiency (SCID).
- •
The TREC assay was designed to detect typical SCID and leaky SCID, but any condition causing low naïve T-cell counts will also be detected.
- •
Newborn screening for SCID using the TREC assay has proven itself to be highly sensitive and cost-efficient. This review covers the history of SCID newborn screening, elaborates on the SCID subtypes and TREC assay limitations, and
Newborn Screening for Severe Combined Immunodeficiency
Section snippets
Key points
History of severe combined immunodeficiency newborn screening
In the United States, NBS programs run at the state level began in the 1960s with the development of a filter paper–based system, onto which newborns’ heel-stick blood samples were spotted and dried. Robert Guthrie’s innovation, spurred by his experience with his son and niece experiencing neurodevelopmental delays from phenylketonuria (PKU), provided blood samples that were easy to obtain and stable. His assay for PKU was accurate, consistent, and inexpensive, providing the paradigm for future
The T-cell receptor excision circle assay for severe combined immunodeficiency
T lymphocytes’ ability to provide adequate defense against a diverse repertoire of pathogens requires an equally diverse range of T-cell receptors (TCR). Recombination of a large number of gene loci organized into segments, known as variable (V), diversity (D), and joining (J) regions. These genes code for TCR chains (and antibody molecules) and lie near genes coding for constant regions. During TCR rearrangement, a series of enzymes introduce double-stranded DNA breaks at specific sites,
Severe combined immunodeficiency subtypes and other conditions detected by T-cell receptor excision circles assay
The TRECs assay was designed to detect typical SCID and leaky SCID, but any condition causing low naïve T-cell counts will also be detected. Typical SCID is diagnosed when there are less than 300 T cells/μL and less than 10% of normal T-cell proliferation on phytohemagglutinin mitogen proliferation culture.24 Frequently, these patients will also exhibit maternal T-cell engraftment owing to survival of maternal T cells that have crossed transplacentally. These cells would normally be eliminated
Results of severe combined immunodeficiency newborn screening
Kwan and colleagues30 published the early results of SCID NBS for more than 3 million infants (n = 3,030,083) from programs in the first 10 states to offer screening, and the Navajo nation. The states included were California, Colorado, Connecticut, Delaware, Massachusetts, Michigan, Mississippi, New York, Texas, and Wisconsin. All programs used the TRECs assay to screen newborns; positive assays were confirmed with flow cytometry to definitively determine T-, B-, and NK-lymphocyte numbers, and
Evaluation of infants with positive T-cell receptor excision circles results
The protocol for evaluating infants with positive (low) TREC results on NBS varies by state.31 Results are not considered abnormal if numbers of both TRECs and β-actin are found to be low, because this would indicate degradation of the DNA sample as opposed to true T-cell lymphopenia. Some states have protocols that will repeat the TREC assay on premature infants, which are known to more frequently have low TRECs despite no intrinsic defect in T-cell production, until these infants reach a
Summary
The TRECs assay is an effective screening tool for SCID. TREC numbers are an indication of naïve T cells, which have recently migrated from the thymus. It follows that the TREC assay detects T-cell lymphopenia from any cause. Most infants with positive TRECs assays do not have SCID (approximately 90%, according to 1 study).30 Congenital syndromes and secondary causes of T-cell lymphopenia are the most common cause of low TREC numbers on NBS. Complete or severe DiGeorge syndrome is the most
References (42)
Primary immunodeficiencies
J Allergy Clin Immunol
(2010)- et al.
Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival
Blood
(2002) - et al.
Mutations in genes required for T-cell development:IL7R,CD45,IL2RG, JAK3, RAG1,RAG2,ARTEMIS,and ADA and severe combined immunodeficiency: HuGE review
GenetMed
(2004) - et al.
Screening for ADA deficiency
J Pediatr
(1974) - et al.
Two-tiered universal newborn screening strategy for severe combined immunodeficiency
Mol Genet Metab
(2005) - et al.
Mutations causing severe combined immunodeficiency: detection with a custom resequencing microarray
Genet Med
(2008) Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles
J Allergy Clin Immunol
(2012)- et al.
Flow cytometric assessment of cord blood as an alternative strategy for population-based screening of severe combined immunodeficiency
J Allergy Clin Immunol
(2013) - et al.
Identification of severe combined immunodeficiency by T-cell receptor excision circles quantification using neonatal Guthrie cards
J Pediatr
(2009) - et al.
Development of population-based newborn screening for severe combined immunodeficiency
J Allergy Clin Immunol
(2005)
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience
J Allergy Clin Immunol
Omenn syndrome: inflammation in leaky severe combined immunodeficiency
J Allergy Clin Immunol
Causes of low neonatal T-cell receptor excision circles: a systematic review
J Allergy Clin Immunol Pract
Limitation of TREC-based newborn screening for ZAP70 severe combined immunodeficiency
Clin Immunol
Newborn screening for severe combined immunodeficiency does not identify bare lymphocyte syndrome
J Allergy Clin Immunol
The Wisconsin approach to newborn screening for severe combined immunodeficiency
J Allergy Clin Immunol
Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening
J Allergy Clin Immunol
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management
J Allergy Clin Immunol
Radiation-sensitive severe combined immunodeficiency: the arguments for and against conditioning before hematopoietic cell transplantation–what to do?
J Allergy Clin Immunol
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study
Blood
Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency
Eur J Pediatr
Cited by (7)
Combined immunodeficiencies
2021, Jornal de PediatriaCitation Excerpt :It is considered a pediatric emergency and an early diagnosis is essential for successful treatment. With the advent of neonatal screening for SCIDs, there has been an improvement in the prognosis of these patients, since the performance of hematopoietic stem cell transplantation (HSCT) in children without infection results in a 2-year survival in approximately 95% of cases.9 However, in Latin America and in many parts of the world where neonatal screening for SCID is not yet routinely available, the diagnosis is made most of the time with infections and severe complications and referral for definitive treatment at a specialized center is delayed.8
Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID)
2022, Therapeutics and Clinical Risk ManagementImmunodeficiency Disorders Resulting in Malabsorption
2021, Textbook of Pediatric Gastroenterology, Hepatology and Nutrition: A Comprehensive Guide to Practice: Second EditionThe co-occurrence of Wilson disease and X-linked agammaglobulinemia in one family highlights the promising diagnostic potential of proteolytic analysis
2020, Molecular Genetics and Genomic Medicine
Disclosure Statement: The authors have nothing to disclose.